Versiti, central Indiana’s main blood center is on a mission to collect plasma from Hoosiers who have recovered from COVID-19 to treat patients currently battling the disease. In our Business of Health segment Kylie Veleta discusses the emergency investigational treatment that was approved by the FDA with Vice President of Transfusion Medicine for Versiti Blood Centers Dr. Dan Waxman.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}